<br><b><font color = "blue">If you have any questions or would like to know more about our special pricing for larger orders please call 1-866-828-3484. WE BEAT ANY COMPETITORS PRICE - GUARANTEED</b></font><br>
Supartz (Sodium Hyaluronate) Joint Fluid Therapy was the first hyaluronan Joint Fluid Therapy approved for use in treating the pain of osteoarthritis (OA). Since 1987, more than 119 million Supartz (Sodium Hyaluronate) Joint Fluid Therapy injections have been sold worldwide, surpassing all other Joint Fluid Therapy products. You can use the world's most prescribed Joint Fluid Therapy with confidence and reliability backed by a wealth of clinical experience.
Supartz (Sodium Hyaluronate) Joint Fluid Therapy is used for the treatment of pain in OA of the knee for patients who have failed to get adequate relief from simple painkillers, exercise and physical therapy.
Supartz (Sodium Hyaluronate) Joint Fluid Therapy is a solution of highly purified, sodium hyaluronate (hyaluronan). Hyaluronan is a natural substance found in particularly high amounts in joint tissues and in the fluid (synovial fluid) that fills the joints. The body's own hyaluronan acts like a lubricant and shock absorber in the synovial fluid of a healthy joint. OA reduces the ability of the synovial fluid to protect and lubricate your joints.
Supartz (Sodium Hyaluronate) Joint Fluid Therapy contains a higher total concentration of the active ingredient per recommended treatment series than any other Joint Fluid Therapy - 125 mg
Fact Sheet:
SUPARTZ Joint Fluid Therapy was the first hyaluronan treatment approved for the relief of osteoarthritis (OA) pain in 1987 in Japan.
Since 1987, over 119 million injections of SUPARTZ Joint Fluid Therapy have been sold worldwide.
SUPARTZ Joint Fluid Therapy is the most prescribed Joint Fluid Therapy in the world.
In clinical studies, SUPARTZ Joint Fluid Therapy has been shown to be effective in the treatment of knee OA pain.
In a 1996 study, SUPARTZ Joint Fluid Therapy produced clinically significant results which were described by the author as the "equivalent of a doubled maximum walking distance combined with a complete loss of night pain."
In clinical studies, SUPARTZ joint fluid therapy had no more incidence of Supartz side effects than the placebo control group.
SUPARTZ Joint Fluid Therapy has a greater amount of active ingredient per treatment series than other Joint Fluid Therapies.
SUPARTZ Joint Fluid Therapy is prescribed to provide osteoarthritis (OA)pain relief. Studies suggest that most patients experiencing relief do so after the full series of five injections. The actual amount and duration of pain relief varies from patient to patient.
A physician administers an injection of SUPARTZ Joint Fluid Therapy (25mg/2.5mL) into your knee once a week for five weeks, for a total of five injections. Your doctor may recommend a local anesthetic prior to injection of SUPARTZ Joint Fluid Therapy to minimize any possible discomfort associated with an injection.
For 48 hours after receiving an injection, you should avoid activities such as jogging, tennis, heavy lifting, or long periods of standing. Keep in mind that no treatment – including SUPARTZ Joint Fluid Therapy – helps every single patient.